CL2008003807A1 - Composicion en polvo nutrifcional que comprende carbhidratos, lipidos con 0,25 a 2,5% de lecitina, 0,5 a 10% de proteina hidrolizada y 90 a 99,5% de proteina intacta; y composiciones nutricionales para bebes. - Google Patents
Composicion en polvo nutrifcional que comprende carbhidratos, lipidos con 0,25 a 2,5% de lecitina, 0,5 a 10% de proteina hidrolizada y 90 a 99,5% de proteina intacta; y composiciones nutricionales para bebes.Info
- Publication number
- CL2008003807A1 CL2008003807A1 CL2008003807A CL2008003807A CL2008003807A1 CL 2008003807 A1 CL2008003807 A1 CL 2008003807A1 CL 2008003807 A CL2008003807 A CL 2008003807A CL 2008003807 A CL2008003807 A CL 2008003807A CL 2008003807 A1 CL2008003807 A1 CL 2008003807A1
- Authority
- CL
- Chile
- Prior art keywords
- protein
- nutritional
- lecithin
- babies
- carbohydrates
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 6
- 108090000623 proteins and genes Proteins 0.000 title abstract 6
- 239000000203 mixture Substances 0.000 title abstract 4
- 150000002632 lipids Chemical class 0.000 title abstract 3
- 235000016709 nutrition Nutrition 0.000 title abstract 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 title abstract 2
- 150000001720 carbohydrates Chemical class 0.000 title abstract 2
- 229940067606 lecithin Drugs 0.000 title abstract 2
- 235000010445 lecithin Nutrition 0.000 title abstract 2
- 239000000787 lecithin Substances 0.000 title abstract 2
- 239000000843 powder Substances 0.000 title abstract 2
- 235000014633 carbohydrates Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pediatric Medicine (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Dairy Products (AREA)
- General Preparation And Processing Of Foods (AREA)
Abstract
Composición que comprende carbohidrato, lípido con 0,25-2,5% de lecitina en peso de lípido total, 0,5-10% de proteína hidrolizada en peso de la proteína total y 90-99,5% de proteína intacta en peso de la proteína total, donde la composición es un polvo nutricional.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1531207P | 2007-12-20 | 2007-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2008003807A1 true CL2008003807A1 (es) | 2009-10-16 |
Family
ID=40788960
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2008003807A CL2008003807A1 (es) | 2007-12-20 | 2008-12-18 | Composicion en polvo nutrifcional que comprende carbhidratos, lipidos con 0,25 a 2,5% de lecitina, 0,5 a 10% de proteina hidrolizada y 90 a 99,5% de proteina intacta; y composiciones nutricionales para bebes. |
Country Status (27)
Country | Link |
---|---|
US (1) | US8361534B2 (es) |
EP (1) | EP2227099B1 (es) |
JP (1) | JP2011507517A (es) |
CN (1) | CN101998835A (es) |
AR (1) | AR069839A1 (es) |
AU (1) | AU2008343687A1 (es) |
BR (1) | BRPI0823502A2 (es) |
CA (1) | CA2708272C (es) |
CL (1) | CL2008003807A1 (es) |
CO (1) | CO6280446A2 (es) |
CR (1) | CR11509A (es) |
DK (1) | DK2227099T3 (es) |
DO (1) | DOP2010000174A (es) |
EC (1) | ECSP10010261A (es) |
ES (1) | ES2535144T3 (es) |
GT (1) | GT201000174A (es) |
HK (1) | HK1145275A1 (es) |
IL (1) | IL206200A (es) |
MX (1) | MX2010006891A (es) |
MY (1) | MY150500A (es) |
NZ (1) | NZ585574A (es) |
PA (1) | PA8808801A1 (es) |
PE (1) | PE20091454A1 (es) |
RU (1) | RU2479219C2 (es) |
TW (1) | TWI418308B (es) |
WO (1) | WO2009085386A2 (es) |
ZA (1) | ZA201004029B (es) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1973406T3 (da) | 2005-12-28 | 2014-06-23 | Advanced Bionutrition Corp | Fremføringsmiddel til probiotiske bakerier omfattende en tør blanding af polysaccharider, saccharider, polyoler i glasform |
US8968721B2 (en) | 2005-12-28 | 2015-03-03 | Advanced Bionutrition Corporation | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
US8460726B2 (en) | 2006-12-18 | 2013-06-11 | Advanced Bionutrition Corporation | Dry food product containing live probiotic |
WO2010111565A2 (en) | 2009-03-27 | 2010-09-30 | Advanced Bionutrition Corporation | Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish |
CN106822080A (zh) | 2009-04-29 | 2017-06-13 | 阿马里纳药物爱尔兰有限公司 | 含有epa和心血管剂的药物组合物以及使用其的方法 |
CN102458109B (zh) | 2009-04-29 | 2015-02-11 | 阿马里纳制药公司 | 稳定的药物组合物和使用其的方法 |
CN102459568A (zh) | 2009-05-26 | 2012-05-16 | 先进生物营养公司 | 包含生物活性微生物和/或生物活性材料的稳定干粉组合物及其制造方法 |
SG10201708950XA (en) | 2009-06-15 | 2017-12-28 | Ian Osterloh | Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy |
TW201112967A (en) * | 2009-09-16 | 2011-04-16 | Abbott Lab | Dryblended nutritional powders |
AU2010298222B2 (en) | 2009-09-23 | 2017-01-05 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same |
US9504750B2 (en) | 2010-01-28 | 2016-11-29 | Advanced Bionutrition Corporation | Stabilizing composition for biological materials |
BR112012018839B1 (pt) | 2010-01-28 | 2020-04-14 | Advanced Bionutrition Corp | composição vítrea seca compreendendo um material bioativo |
CN103140145B (zh) | 2010-08-13 | 2014-08-20 | 高级生物营养公司 | 用于生物材料的干的贮存稳定用组合物 |
US11712429B2 (en) | 2010-11-29 | 2023-08-01 | Amarin Pharmaceuticals Ireland Limited | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
WO2012074930A2 (en) | 2010-11-29 | 2012-06-07 | Amarin Pharma, Inc. | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
TWI561175B (en) * | 2011-03-31 | 2016-12-11 | Meiji Co Ltd | Flowable nutrition composition containing l-arginine and method for producing the same |
US20120269929A1 (en) * | 2011-04-22 | 2012-10-25 | Hugh Lippman | Fortified Milk-Based Nutritional Compositions |
SG2014008478A (en) * | 2011-08-16 | 2014-04-28 | Abbott Lab | Use of ultrasonic energy in the production of nutritional powders |
DK2757898T3 (en) | 2011-09-20 | 2016-01-11 | Abbott Lab | Powdered nutritional formulations with spray-dried plant protein |
US11291643B2 (en) | 2011-11-07 | 2022-04-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
US20130131170A1 (en) | 2011-11-07 | 2013-05-23 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
EP2800469B1 (en) | 2012-01-06 | 2021-08-25 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering levels of high-sensitivity (hs-crp) in a subject |
JP2015522029A (ja) | 2012-06-29 | 2015-08-03 | アマリン ファーマシューティカルス アイルランド リミテッド | スタチン療法中の患者における心血管系イベントの危険性を減少させる方法 |
WO2014074552A2 (en) | 2012-11-06 | 2014-05-15 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy |
US20140187633A1 (en) | 2012-12-31 | 2014-07-03 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis |
US9452151B2 (en) | 2013-02-06 | 2016-09-27 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing apolipoprotein C-III |
US9624492B2 (en) | 2013-02-13 | 2017-04-18 | Amarin Pharmaceuticals Ireland Limited | Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof |
US20140271841A1 (en) | 2013-03-15 | 2014-09-18 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin |
US20140328970A1 (en) * | 2013-05-03 | 2014-11-06 | Mead Johnson Nutrition Company | Nutritional Composition Comprising Whey and Hydrolyzed Casein and Uses Thereof |
US10966968B2 (en) | 2013-06-06 | 2021-04-06 | Amarin Pharmaceuticals Ireland Limited | Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof |
US20150065572A1 (en) | 2013-09-04 | 2015-03-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing prostate cancer |
US9585859B2 (en) | 2013-10-10 | 2017-03-07 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy |
US10639334B2 (en) * | 2014-01-07 | 2020-05-05 | Mead Johnson Nutrition Company | Pediatric nutritional composition with milk peptides for healthy growth and development |
US10561631B2 (en) | 2014-06-11 | 2020-02-18 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing RLP-C |
WO2015195662A1 (en) | 2014-06-16 | 2015-12-23 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids |
US20170202260A1 (en) * | 2014-07-21 | 2017-07-20 | Abbott Laboratories | Nutritional powder with specific antioxidants |
WO2016057818A1 (en) * | 2014-10-08 | 2016-04-14 | Abbott Laboratories | Nutritional compositions comprising an oxidizable component and water-soluble plant extract |
JP6889699B2 (ja) | 2015-07-29 | 2021-06-18 | アドバンスド バイオニュートリション コープ. | 特定栄養用途のための安定乾燥プロバイオティクス組成物 |
US10406130B2 (en) | 2016-03-15 | 2019-09-10 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids |
WO2018213663A1 (en) | 2017-05-19 | 2018-11-22 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides in a subject having reduced kidney function |
WO2019090093A1 (en) * | 2017-11-03 | 2019-05-09 | Advanced Bionutrition Corp. | Composition containing viable microorganisms and methods of making |
US11058661B2 (en) | 2018-03-02 | 2021-07-13 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L |
CN112218630A (zh) | 2018-09-24 | 2021-01-12 | 阿马里纳药物爱尔兰有限公司 | 降低受试者的心血管事件的风险的方法 |
WO2022225896A1 (en) | 2021-04-21 | 2022-10-27 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing the risk of heart failure |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4830861A (en) * | 1988-07-14 | 1989-05-16 | Bristol-Myers Company | Low manganese high protein rice flour |
US5013569A (en) * | 1990-05-21 | 1991-05-07 | Century Laboratories, Inc. | Infant formula |
US5021245A (en) * | 1990-05-22 | 1991-06-04 | Abbott Laboratories | Infant formula containing a soy polysaccharide fiber source |
US5405637A (en) * | 1993-06-30 | 1995-04-11 | Bristol-Myers Squibb Company | Milk protein partial hydrolysate and infant formula containing same |
DK0739207T3 (da) * | 1994-01-10 | 2008-12-15 | Abbott Lab | Enteral formulering med ribonucleotider |
US6136858A (en) | 1994-01-10 | 2000-10-24 | Abbott Laboratories | Infant formula and methods of improving infant stool patterns |
JP3878690B2 (ja) * | 1995-09-29 | 2007-02-07 | 森永乳業株式会社 | 乳幼児用乳糖含有食品組成物 |
SK112399A3 (en) | 1997-02-21 | 2000-12-11 | Abbott Lab | Methods and compositions for reducing the incidence of necrotizing enterocolitis |
EP1034704A1 (en) * | 1999-03-12 | 2000-09-13 | Societe Des Produits Nestle S.A. | Nutritional composition intended for specific gastro-intestinal maturation in premature mammals |
US6365218B1 (en) * | 2000-02-04 | 2002-04-02 | Abbott Laboratories | Pediatric formula and methods for providing nutrition and improving tolerance |
US6207638B1 (en) * | 2000-02-23 | 2001-03-27 | Pacifichealth Laboratories, Inc. | Nutritional intervention composition for enhancing and extending satiety |
DE60221621T2 (de) | 2001-11-26 | 2008-05-21 | Nestec S.A. | Lagerstabiles Nahrungsmittelprodukt enthaltend Molkenprotein, Verfahren zu seiner Herstellung und Verwendung |
RU2262867C2 (ru) * | 2002-02-14 | 2005-10-27 | Катков Юрий Адольфович | Бад к пище для улучшения репродукции человека (варианты) |
TWI317636B (en) | 2002-11-22 | 2009-12-01 | Meiji Dairies Corp | Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress |
US7090879B2 (en) | 2004-03-18 | 2006-08-15 | Abbott Laboratories | Nutritional formula containing select carotenoid combinations |
ES2359573T3 (es) | 2004-12-27 | 2011-05-24 | Nestec S.A. | Empleo de una fórmula para bebes con un reducido contenido en proteínas. |
US20070281054A1 (en) * | 2006-05-31 | 2007-12-06 | Abbott Laboratories | Organic powder nutritional formula containing select carbohydrate combinations |
-
2008
- 2008-10-28 US US12/260,062 patent/US8361534B2/en active Active
- 2008-10-29 BR BRPI0823502A patent/BRPI0823502A2/pt not_active IP Right Cessation
- 2008-10-29 RU RU2010129985/13A patent/RU2479219C2/ru not_active IP Right Cessation
- 2008-10-29 WO PCT/US2008/081534 patent/WO2009085386A2/en active Application Filing
- 2008-10-29 DK DK08868815.5T patent/DK2227099T3/en active
- 2008-10-29 CA CA2708272A patent/CA2708272C/en active Active
- 2008-10-29 AU AU2008343687A patent/AU2008343687A1/en not_active Abandoned
- 2008-10-29 ES ES08868815.5T patent/ES2535144T3/es active Active
- 2008-10-29 NZ NZ585574A patent/NZ585574A/en unknown
- 2008-10-29 JP JP2010539545A patent/JP2011507517A/ja active Pending
- 2008-10-29 CN CN2008801216010A patent/CN101998835A/zh active Pending
- 2008-10-29 MY MYPI20102839 patent/MY150500A/en unknown
- 2008-10-29 EP EP08868815.5A patent/EP2227099B1/en active Active
- 2008-10-29 MX MX2010006891A patent/MX2010006891A/es active IP Right Grant
- 2008-11-25 TW TW097145503A patent/TWI418308B/zh not_active IP Right Cessation
- 2008-12-17 PE PE2008002090A patent/PE20091454A1/es not_active Application Discontinuation
- 2008-12-18 PA PA20088808801A patent/PA8808801A1/es unknown
- 2008-12-18 CL CL2008003807A patent/CL2008003807A1/es unknown
- 2008-12-19 AR ARP080105557A patent/AR069839A1/es not_active Application Discontinuation
-
2010
- 2010-05-31 CO CO10065323A patent/CO6280446A2/es not_active Application Discontinuation
- 2010-06-04 ZA ZA2010/04029A patent/ZA201004029B/en unknown
- 2010-06-06 IL IL206200A patent/IL206200A/en active IP Right Grant
- 2010-06-11 DO DO2010000174A patent/DOP2010000174A/es unknown
- 2010-06-15 GT GT201000174A patent/GT201000174A/es unknown
- 2010-06-16 EC EC2010010261A patent/ECSP10010261A/es unknown
- 2010-06-17 CR CR11509A patent/CR11509A/es not_active Application Discontinuation
- 2010-12-16 HK HK10111817.6A patent/HK1145275A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CO6280446A2 (es) | 2011-05-20 |
CR11509A (es) | 2010-12-16 |
ES2535144T3 (es) | 2015-05-06 |
MX2010006891A (es) | 2010-10-15 |
DOP2010000174A (es) | 2010-06-30 |
DK2227099T3 (en) | 2015-06-15 |
MY150500A (en) | 2014-01-30 |
RU2479219C2 (ru) | 2013-04-20 |
TW200934396A (en) | 2009-08-16 |
WO2009085386A2 (en) | 2009-07-09 |
EP2227099B1 (en) | 2015-03-04 |
IL206200A (en) | 2015-05-31 |
IL206200A0 (en) | 2010-12-30 |
BRPI0823502A2 (pt) | 2018-03-20 |
HK1145275A1 (en) | 2011-04-15 |
US20090162521A1 (en) | 2009-06-25 |
US8361534B2 (en) | 2013-01-29 |
CN101998835A (zh) | 2011-03-30 |
PA8808801A1 (es) | 2009-07-23 |
AR069839A1 (es) | 2010-02-24 |
EP2227099A2 (en) | 2010-09-15 |
TWI418308B (zh) | 2013-12-11 |
CA2708272C (en) | 2015-10-13 |
JP2011507517A (ja) | 2011-03-10 |
RU2010129985A (ru) | 2012-01-27 |
PE20091454A1 (es) | 2009-10-25 |
AU2008343687A1 (en) | 2009-07-09 |
ZA201004029B (en) | 2011-04-28 |
NZ585574A (en) | 2012-06-29 |
CA2708272A1 (en) | 2009-07-09 |
WO2009085386A3 (en) | 2009-09-17 |
GT201000174A (es) | 2012-04-03 |
ECSP10010261A (es) | 2010-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2008003807A1 (es) | Composicion en polvo nutrifcional que comprende carbhidratos, lipidos con 0,25 a 2,5% de lecitina, 0,5 a 10% de proteina hidrolizada y 90 a 99,5% de proteina intacta; y composiciones nutricionales para bebes. | |
CL2008003809A1 (es) | Composicion en polvo nutricional que comprende carboidratos, lipidos con 0,25 a 2,5% de lecitina, 90 a 99,5% de proteina intacta y 0,5 a 10% de proteina de suero con un grado de hidrolisis de entre 23 y 90%; y composiciones nutricionales para bebes. | |
CL2007002084A1 (es) | Ingrediente lacteo enriquecido en fosfolipidos y esfingolipidos, en que el porcentaje de fosfolipidos es mayor a 36% con respeto al peso de la materia seca del ingrediente; procedimiento de obtencion; composicion alimentaria o aditivo que lo contiene; composicion farmaceutica o cosmetica; y su uso. | |
CL2011003078A1 (es) | Uso de una composicion nutricional para mantener, sostener y/o mejorar el desempeno cognitivo en un nino de 3 a 6 anos, que comprende al menos una fuente de proteina, una fuente de carbohidratos, una fuente de lipido, un microorganismo probiotico, y prebioticos, en donde la fuente de lipido comprende acido docosahexanoico (dha). | |
AR098598A1 (es) | Composición nutricional con probióticos estables | |
CR20150097A (es) | Composición inmunogénica | |
EA201070419A1 (ru) | Состав для регулирования метаболизма липидов | |
BR112012031183A2 (pt) | líquidos nutricionais substancialmente claros compreendendo proteína de cálcio hmb e solúvel | |
BR112013000537A2 (pt) | composição aquosa contendo bromexina | |
ECSP12011964A (es) | Anticuerpos de unión al dominio extracelular 4 de csf-1r | |
BR112012020857A2 (pt) | substrato gerador de aerossol para artigos para fumar | |
BR112013005235A2 (pt) | "métodos e sistemas para processamento de misturas de açúcar e composições resultantes". | |
BR112012023288A2 (pt) | composição nutricional e uso de substituto do açúcar | |
BR112014027820A2 (pt) | controle dietário de doença celíaca e alergias alimentares | |
BR112014029286A2 (pt) | composição cosmética sólida, processo para sua produção, produto e método cosmético | |
BR112015029853A2 (pt) | uso de uma composição farmacêutica | |
CL2011000893A1 (es) | Composicion nutricional para infantes en que comprende proteinas parcialmente hidrolizadas con un grado de hidrolisis de entre 5 y 40%, una fuente de lipido y una fuente de carbohidrato seleccionado entre almidon de cereal o de papa; y su uso para el manejo de la regurgitacion. | |
UY30215A1 (es) | Derivados de cromanol sustituidos, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y aplicaciones | |
BR112014019572A8 (pt) | Composição detergente | |
PE20130208A1 (es) | Composicion nutricional | |
ECSP13012799A (es) | Uso de composiciones nutricionales que incluyen lactoferrinas para mejorar la resistencia a enfermedades y condiciones | |
BR112013015634B8 (pt) | composição que compreende gordura, proteína e carboidratos, uso da composição, uso de fibras alimentares, processo para preparação de uma fórmula infantil e processo para preparação da composição | |
BR112012026346A2 (pt) | formulações inovadoras de ingredientes (s) ativo(s) de origem vegetal ou seus análogos sintéticos ou de extrato(s) de origem vegetal que os inclui, e de lacitina | |
PE20151878A1 (es) | Fibra de madera acetilada | |
BR112013032992A2 (pt) | composições de gordura vegetal hidrogenada |